| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Werner Milton H. is a President And CEO at Inhibikase Therapeutics, Inc.. Recent SEC Form 4 filings include 8 buys and 0 sells.
Estimated insider holdings value: $11.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 5,000 | $0.80 | $4,000.00 | - | -32.3% | -53.2% | |
| May 27, 2022 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 5,000 | $0.98 | $4,880.00 | - | -6.0% | -34.2% | |
| May 20, 2022 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 10,000 | $0.60 | $6,000.00 | +0.2% | +22.2% | -2.5% | |
| Nov 17, 2021 | IKT Inhibikase Therapeutics, Inc. | President And CEO | Buy | 23,589 | $1.97 | $46,558.14 | +25.0% | -37.4% | -64.9% |